Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00320749
Status:
COMPLETED
Last Update Posted:
2016-06-27
First Post:
2006-04-28
Brief Title:
Capecitabine Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
Sponsor:
Tony Bekaii-Saab
Organization:
Ohio State University Comprehensive Cancer Center
Organization Data
Organization:
Ohio State University Comprehensive Cancer Center
Class:
OTHER
Study ID:
OSU-05058
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tony Bekaii-Saab
Lead Sponsor Class:
OTHER
Responsible Party:
Tony Bekaii-Saab
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Ohio State University Comprehensive Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of Michigan Rogel Cancer Center | OTHER |